RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+2.88%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$292M
AUM Growth
+$292M
(+6.3%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
10.13%
Top 10 Holdings %
Top 10 Hldgs %
72.73%
Holding
39
New
5
Increased
13
Reduced
10
Closed
3
Top Buys
| 1 |
BLUE
bluebird bio
BLUE
|
$16.7M |
| 2 |
SPDR Gold Trust
GLD
|
$10.5M |
| 3 |
Bristol-Myers Squibb
BMY
|
$7.36M |
| 4 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$5.64M |
| 5 |
VIVE
VIVEVE MED INC
VIVE
|
$3.34M |
Top Sells
| 1 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$7.54M |
| 2 |
Omeros
OMER
|
$3.84M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
$2.9M |
| 4 |
Lipocine
LPCN
|
$2.44M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$1.88M |
Sector Composition
| 1 | Healthcare | 81.34% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Masimo
MASI
$7.43B
| $1.36M | 0.46% |
25,900
| – | – |
|
|
AXDX
27
DELISTED
Accelerate Diagnostics
AXDX
| $1.08M | 0.37% |
74,843
-42,333
| -36% | -$609K |
|
|
MRTX
28
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $716K | 0.24% |
131,052
-297,405
| -69% | -$1.62M |
|
|
MDRX
29
DELISTED
Veradigm Inc. Common Stock
MDRX
| $610K | 0.21% |
48,000
| – | – |
|
|
TMBR
30
DELISTED
Timber Pharmaceuticals, Inc.
TMBR
| $455K | 0.16% |
700,636
| – | – |
|
31
Natera
NTRA
$23B
| $382K | 0.13% |
31,693
| – | – |
|
|
ALPN
32
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $138K | 0.05% |
30,000
| – | – |
|
|
NVRO
33
DELISTED
NEVRO CORP.
NVRO
| – | – |
0
| – | – |
|
34
MannKind Corp
MNKD
$1.69B
| – | – |
0
| – | – |
|
|
35
Lipocine
LPCN
$15.7M
| – | – |
-240,438
| Closed | -$2.44M |
|
36
Berkshire Hathaway Class B
BRK.B
$1.08T
| – | – |
-50
| Closed | -$7K |
|
|
ADAP
37
Adaptimmune Therapeutics
ADAP
$13.9M
| – | – |
-7,691
| Closed | -$63K |
|